JPRN-jRCT2080223699已完成2 期
Phase II study of NS-17 in elderly patients with acute myeloid leukemia.
ippon Shinyaku Co., Ltd.0 个研究点目标入组 50 人开始时间: 2017年11月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 65age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1. AML patients who are diagnosed of one of the following:
- •Newly diagnosed, histologically confirmed de novo AML or,
- •AML secondary to prior myelodysplastic disease or,
- •AML secondary to exposure to potentially leukemogenic therapies or agents with the primary malignancy.
- •2. Patients with bone marrow blasts>=30%.
- •3. Patients whose ECOG PS is 0, 1 or 2
排除标准
- •1. Patients with previous cytotoxic treatment for AML.
- •2. Patients with previous treatment with hypomethylating agents or cytarabine.
研究者
相似试验
已完成
2 期
Phase II study of S-1 for elderly patients with unresectable pancreatic cancerpancreatic cancerJPRN-UMIN000006369Chigasaki Municipal Hospital21
已完成
2 期
Phase 2 study of S-1 for elderly patients with advanced non-small cell lung cancernon-small cell lung cancerJPRN-UMIN000006527Kitasato University School of Medicine Department of Respiratory Medicine35
已完成
2 期
A phase 2 study of S-812217 in patients with major depressive disorderJPRN-jRCT2080225180SHIONOGI & CO., LTD.240
已完成
2 期
Phase II study of TS-1 in elderly patients with unresectable non-small cell lung canceron-small cell lung cancerJPRN-UMIN000000793agasaki Thoracic Oncology Group32
招募中
3 期
A phase 3 study of S-812217 in patients with major depressive disorderdepressionJPRN-jRCT2031210577agata Tsutae400